Skip to main content
. 2022 May 19;14(10):4500–4512. doi: 10.18632/aging.204089

Table 5. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) of clinical statuses associated with genotypic frequencies of histamine receptor H1 (HRH1) rs901865 in non-betel-quid chewers.

Variable Non-betel-quid chewers (N=311)
CC (N=254) CT+TT (N=57) AOR (95% CI)a p value
Clinical stage
Stage I+II 116 (45.7%) 24 (42.1%) 1.000 (reference) 0.582
Stage III+IV 138 (54.3%) 33 (57.9%) 1.179 (0.656~2.121)
Tumor size
≤T2 114 (44.9%) 30 (52.6%) 1.000 (reference) 0.249
>T2 140 (55.1%) 27 (47.4%) 0.709 (0.396~1.272)
Lymph node metastasis
No 164 (64.6%) 32 (56.1%) 1.000 (reference) 0.189
Yes 90 (35.4%) 25 (43.9%) 1.485 (0.823~2.679)
Metastasis
M0 252 (99.2%) 56 (98.3%) 1.000 (reference) 0.412
M1 2 (0.8%) 1 (1.7%) 2.798 (0.240~32.609)
Cell differentiated grade
Well 23 (9.1%) 9 (15.8%) 1.000 (reference) 0.151
Moderately or poorly 231 (90.9%) 48 (84.2%) 0.542 (0.235~1.251)

Cell differentiate grade: grade I, well differentiated; grade II, moderately differentiated; grade III, poorly differentiated.

aThe AORs with their 95% CIs were estimated by multiple logistic regression models after controlling for age, cigarette smoking, and alcohol consumption.